Paris, France

Michel Mazzuca

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Hospices Civils De Lyon, Université René Descartes Paris 5. Active years: 2019.


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michel Mazzuca: Innovator in Protein Chip Technology

Introduction

Michel Mazzuca is a notable inventor based in Paris, France. He has made significant contributions to the field of medicine, particularly in research and diagnosis. His innovative work focuses on developing tools that enhance the detection of antibodies in biological samples.

Latest Patents

Michel Mazzuca holds a patent for "Protein chips, preparation and use thereof." This invention relates to a novel tool designed for detecting antibodies in biological samples originating from mammals. The protein chip can be utilized in screening for new targets involved in autoimmune diseases, especially those affecting the nervous system. Additionally, the invention encompasses methods for producing the tool and kits that facilitate its use.

Career Highlights

Throughout his career, Michel Mazzuca has worked with esteemed institutions, including University Claude Bernard - Lyon 1 and Université René Descartes Paris 5. His research has contributed to advancements in medical diagnostics and therapeutic strategies.

Collaborations

Michel has collaborated with notable colleagues such as Florian Lesage and Marie-Madeleine Larroque. Their joint efforts have furthered the development of innovative solutions in the medical field.

Conclusion

Michel Mazzuca's work in protein chip technology exemplifies the intersection of innovation and medicine. His contributions are paving the way for improved diagnostic tools that can significantly impact the understanding and treatment of autoimmune diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…